BioCryst Pharmaceuticals Shares Outstanding 2010-2025 | BCRX

BioCryst Pharmaceuticals shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
BioCryst Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2024 207
2023 192
2022 186
2021 179
2020 167
2019 116
2018 103
2017 84
2016 74
2015 73
2014 67
2013 55
2012 49
2011 45
2010 45
2009 39
BioCryst Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
2025-03-31 215
2024-12-31 207
2024-09-30 207
2024-06-30 206
2024-03-31 206
2023-12-31 192
2023-09-30 190
2023-06-30 189
2023-03-31 189
2022-12-31 186
2022-09-30 186
2022-06-30 186
2022-03-31 185
2021-12-31 179
2021-09-30 179
2021-06-30 178
2021-03-31 177
2020-12-31 167
2020-09-30 177
2020-06-30 162
2020-03-31 154
2019-12-31 116
2019-09-30 110
2019-06-30 110
2019-03-31 110
2018-12-31 103
2018-09-30 105
2018-06-30 99
2018-03-31 99
2017-12-31 84
2017-09-30 84
2017-06-30 80
2017-03-31 75
2016-12-31 74
2016-09-30 74
2016-06-30 74
2016-03-31 74
2015-12-31 73
2015-09-30 73
2015-06-30 77
2015-03-31 72
2014-12-31 67
2014-09-30 72
2014-06-30 64
2014-03-31 60
2013-12-31 55
2013-09-30 57
2013-06-30 53
2013-03-31 51
2012-12-31 49
2012-09-30 51
2012-06-30 49
2012-03-31 47
2011-12-31 45
2011-09-30 45
2011-06-30 45
2011-03-31 45
2010-12-31 45
2010-09-30 45
2010-06-30 45
2010-03-31 44
2009-12-31 39
2009-09-30 38
2009-06-30 38
2009-03-31 38
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.107B $0.451B
BioCryst Pharmaceuticals, Inc. is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections. The company is advancing multiple internal programs toward potential commercialization including Fodosine in oncology, BCX-4208 in transplantation and autoimmune diseases and peramivir in seasonal and life threatening influenza. BioCryst has a worldwide partnership with Roche for the development and commercialization BCX-4208, and is collaborating with Mundipharma for the development and commercialization of Fodosine in markets across Europe, Asia, Australia and certain neighboring countries.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $83.493B 31.32
Zoetis (ZTS) United States $71.874B 26.82
Daiichi Sankyo, - (DSNKY) Japan $49.349B 25.11
Takeda Pharmaceutical (TAK) Japan $45.565B 9.06
Sandoz Group AG (SDZNY) Switzerland $21.424B 0.00
Summit Therapeutics (SMMT) United States $18.871B 0.00
Merck (MKKGY) Germany $17.157B 12.57
United Therapeutics (UTHR) United States $13.969B 12.36
Shionogi (SGIOY) Japan $13.560B 13.59
Neurocrine Biosciences (NBIX) United States $11.931B 40.87
IPSEN (IPSEY) France $9.964B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.038B 65.35
Stevanato Group S.p.A (STVN) Italy $7.265B 44.43
Madrigal Pharmaceuticals (MDGL) United States $6.156B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.631B 0.00
Ionis Pharmaceuticals (IONS) United States $5.332B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.875B 14.83
Soleno Therapeutics (SLNO) United States $3.694B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.966B 10.39
Crinetics Pharmaceuticals (CRNX) United States $2.804B 0.00
Hypermarcas (HYPMY) Brazil $2.702B 17.77
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.279B 12.32
NewAmsterdam Pharma (NAMS) Netherlands $2.033B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.713B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.665B 0.00
Indivior (INDV) United States $1.557B 6.60
Evotec AG (EVO) Germany $1.424B 0.00
ARS Pharmaceuticals (SPRY) United States $1.397B 0.00
Guardian Pharmacy Services (GRDN) United States $1.396B 0.00
Dyne Therapeutics (DYN) United States $1.337B 0.00
Ocular Therapeutix (OCUL) United States $1.163B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.127B 22.54
Harrow (HROW) United States $0.981B 0.00
Ardelyx (ARDX) United States $0.955B 0.00
Collegium Pharmaceutical (COLL) United States $0.947B 5.11
Avadel Pharmaceuticals (AVDL) Ireland $0.885B 0.00
Enliven Therapeutics (ELVN) United States $0.831B 0.00
Cronos Group (CRON) Canada $0.798B 0.00
Xeris Biopharma Holdings (XERS) United States $0.769B 0.00
Akebia Therapeutics (AKBA) United States $0.738B 0.00
AleAnna (ANNA) United States $0.680B 0.00
KalVista Pharmaceuticals (KALV) United States $0.590B 0.00
USANA Health Sciences (USNA) United States $0.554B 12.05
Regulus Therapeutics (RGLS) United States $0.548B 0.00
Xencor (XNCR) United States $0.535B 0.00
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Bioventus (BVS) United States $0.534B 13.54
Savara (SVRA) United States $0.503B 0.00
Relay Therapeutics (RLAY) United States $0.490B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.484B 0.00
Zevra Therapeutics (ZVRA) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.471B 0.00
Altimmune (ALT) United States $0.453B 0.00
CytoDyn (CYDY) United States $0.448B 0.00
Siga Technologies (SIGA) United States $0.438B 9.15
Oruka Therapeutics (ORKA) United States $0.396B 0.00
Tourmaline Bio (TRML) United States $0.388B 0.00
Organogenesis (ORGO) United States $0.382B 0.00
Verve Therapeutics (VERV) United States $0.377B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.374B 10.12
Heron Therapeutics (HRTX) United States $0.287B 0.00
Nature's Sunshine Products (NATR) United States $0.266B 24.52
ProKidney (PROK) United States $0.226B 0.00
Aquestive Therapeutics (AQST) United States $0.225B 0.00
MediWound (MDWD) Israel $0.215B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.208B 0.00
OmniAb (OABI) United States $0.175B 0.00
Avita Medical (RCEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.172B 0.00
Esperion Therapeutics (ESPR) United States $0.169B 0.00
4D Molecular Therapeutics (FDMT) United States $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Wellgistics Health (WGRX) United States $0.162B 0.00
Liminatus Pharma (LIMN) $0.160B 0.00
Journey Medical (DERM) United States $0.157B 0.00
Profound Medical (PROF) Canada $0.154B 0.00
Inhibikase Therapeutics (IKT) United States $0.146B 0.00
Aclaris Therapeutics (ACRS) United States $0.140B 0.00
Korro Bio (KRRO) United States $0.139B 0.00
Aldeyra Therapeutics (ALDX) United States $0.135B 0.00
Protara Therapeutics (TARA) United States $0.125B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.124B 0.00
Larimar Therapeutics (LRMR) United States $0.124B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lyell Immunopharma (LYEL) United States $0.121B 0.00
Nektar Therapeutics (NKTR) United States $0.118B 0.00
Achieve Life Sciences (ACHV) Canada $0.109B 0.00
VAXART, INC (VXRT) United States $0.104B 0.00
Lexeo Therapeutics (LXEO) United States $0.102B 0.00
Cassava Sciences (SAVA) United States $0.099B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.095B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Cardiol Therapeutics (CRDL) Canada $0.088B 0.00
Champions Oncology (CSBR) United States $0.083B 13.59
Galectin Therapeutics (GALT) United States $0.081B 0.00
Arch Biopartners (ACHFF) Canada $0.081B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.074B 55.11
ESSA Pharma (EPIX) Canada $0.074B 0.00
Pyxis Oncology (PYXS) United States $0.071B 0.00
Dominari Holdings (DOMH) United States $0.069B 0.00
Inotiv (NOTV) United States $0.069B 0.00
Unicycive Therapeutics (UNCY) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Telomir Pharmaceuticals (TELO) United States $0.063B 0.00
Surrozen (SRZN) United States $0.063B 0.00
Context Therapeutics (CNTX) United States $0.062B 0.00
Metagenomi (MGX) United States $0.062B 0.00
Nutriband (NTRB) United States $0.060B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.050B 0.00
Mural Oncology (MURA) Ireland $0.048B 0.00
PMV Pharmaceuticals (PMVP) United States $0.047B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.046B 0.00
NRx Pharmaceuticals (NRXP) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.041B 0.00
Iterum Therapeutics (ITRM) Ireland $0.037B 0.00
ElectroCore (ECOR) United States $0.037B 0.00
Acrivon Therapeutics (ACRV) United States $0.036B 0.00
FibroGen (FGEN) United States $0.034B 0.00
Rafael Holdings (RFL) United States $0.033B 0.00
SCYNEXIS (SCYX) United States $0.030B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
CASI Pharmaceuticals (CASI) China $0.024B 0.00
Tempest Therapeutics (TPST) United States $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.018B 0.00
DURECT (DRRX) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.016B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.012B 0.00
Vivos Therapeutics (VVOS) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
ProPhase Labs (PRPH) United States $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.010B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.77
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.007B 0.00
Carisma Therapeutics (CARM) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Klotho Neurosciences (KLTO) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00